Composition comprising the purified extract of bee venom for preventing and treating degenerative brain disease

Inactive Publication Date: 2012-04-05
HUONS
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0049]Inventive extract of the present invention have no toxicity and adverse effect therefore; they can be used with safe.

Problems solved by technology

At the present, the drug therapy using by levodopa, a representative drug for treating Parkinson's disease, has been conventionally available till now however it has several problems for example, the need to inconsistent administration, the therapeutic limit to fundamental treatment etc or disadvantages for example, a neuronal damage caused by dopamine administration, the reduced drug potency due to drug intolerance, post-treatment complication such as the disorder of involuntary movement, the aggravated movement disorder, the other adverse action associated from long-term drug therapy etc (Judith L. Miller, Parkinson's disease primer, Geriatric Nursing, 23(2), pp 69-73, 2002; Fabio Danisi, Parkinson's disease-Therapeutic strategies to improve patient function and quality of life, Geriatrics, 57(3), pp 46-50, 2002).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition comprising the purified extract of bee venom for preventing and treating degenerative brain disease
  • Composition comprising the purified extract of bee venom for preventing and treating degenerative brain disease
  • Composition comprising the purified extract of bee venom for preventing and treating degenerative brain disease

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of the Crude Purified Extract of Bee Venom

[0061]10.0 g of dried bee venom collected from honey bee was dissolved in waster and the impurities were removed by filtration using by syringe filter (Minisart RC 15, 0.20 microm, Sartorius Co. Germany). The filtrate was dried with lyophilizer (FDCF-12012, Operon Co. Korea) to obtain 9.76 g of dried crude purified extract of bee venom (designated as “HP-01” hereinafter). The dried powder was used in following experiments as a test sample.

example 2

Preparation of Purified Extract of Bee Venom Using by Gel Filtration Chromatography

[0062]100 mg of the dried crude purified extract prepared in Example 1 was dissolved in 1.0 ml of distilled water (HPLC grade) and subject to gel filtration chromatography according the condition disclosed in Table 1 in order to afford 20 fractions. Each fraction was added to protein dialysis membrane (Spectra / por 7, Spectrum Co. USA) and the membrane was dipped into a cylindrical glass flask containing 500 ml of distilled water (HPLC grade) to perform dialysis with stirring for 90 mins. After finishing desalting process with dialysis, the desalted solution present within the membrane was lyophilized for 3 days using by lyophilizer (FDCF-12012, Operon Co. Korea) and each purified fraction was collected to obtain 74 mg of purified extract of bee venom (yield: 74%) (designated as “HP-01G” hereinafter).

TABLE 1Condition of Gel filtration analysisPumpKnauer Smartline Pump 1000 (A50303)DetectorKnauer S2600 ...

example 3

Preparation of Purified Extract of Bee Venom Using by Salting-Out Method

[0065]100 mg of the dried crude purified extract prepared in Example 1 was dissolved in 5.0 ml of distilled water (HPLC grade) to be adjusted to 20 mg / ml and the solution was subject to salting-in process by adding ammonium sulfate with stirring for 1 hour at room temperature to be 30% ammonium sulfate solution dropwisely. The solution was further stirred for 1 hour at room temperature and subjected to salting-out process by adding ammonium sulfate dropwisely to be 80% solution.

[0066]The solution was left alone for 2 hours at 0° C. to provide enough time to sufficient salting out process and centrifuged for 15 mins with the speed of 15,000 rpm by using ultra-speed centrifuges (Ultra 5.0, Hanil Science Medical Co. Ltd, Korea). The supernatant was collected and the precipitant was dissolved in 5 ml of distilled water (HPLC grade) in order that each one was subjected to be desalted and lyophilized to obtain 19 mg o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases and the use thereby. The purified extract of bee venom shows potent inhibitory effect on microglial cell activation and abnormal circling behavior using by animal model of degenerative brain disease as well as potent cell-protective activity therefore, it can be useful in treating and preventing the degenerative brain disease as a medicament.

Description

TECHNICAL FIELD[0001]The present invention relates to a composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases and the use thereby.BACKGROUND ART[0002]In the twentieth century, as the average life span of human has been increasing with the rapid development of life science and medicine, new social problems including increased population ratio of older people are coming to the front, especially, the geriatric neuronal diseases such as stroke, Alzheimer's disease (AD), Parkinson's disease (PD) etc., which are fatal functional disorder of neuronal system, have been increased.[0003]Especially, Parkinson's disease is caused by the neuronal death of substantia nigra pars compacta in brain and is frequently occurring neuronal disease. In particular, in-diopathic Parkinson's disease predominates over 80% among the people suffering from Parkinson's disease and is an etiological cause by severe disorder in the older people (Ennio Espos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/46A61P25/16A61P25/28
CPCA61K9/0019A61K9/1623A61K9/2018A61K9/4858A61K38/12A61K31/137A61K38/465A61K38/1767A61K31/417A61K2300/00A61P25/00A61P25/16A61P25/28A61K9/19A61K35/63
Inventor YOON, SEONG TAESHIN, DAE HEELIM, BANG HOKIM, JAE YOUNGCHOI, JAE SEOK
Owner HUONS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap